TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

108.00$ +33.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
94.5% 87.7% 84.4% 2.5% 5.3% 3.4% 27.5% 32.6%
13.8% 22.5% 24.1% 2.3% 4.3% 2.1% 7.2% 8.5%
93.4% 85.7% 82.6% 2.3% 4.3% 2.1% 25.6% 31.0%
0.1% 0.3% 0.5% 0.8% 0.6%
-0.1% 0.4% 0.5% 0.6% 0.5%
63.6% 26.7% 19.5% 0.0%
31.6% 52.4% 59.0% 67.6% 63.3%
12.6% 13.4% 20.5% 3.2% 17.1% 20.0% 16.1% 11.8%
10.8% 7.1% 11.9% 1.0% 2.4% 3.6% 2.6% 2.7%
0.3% 0.9% 0.8% 0.1% 0.2% 0.3% 0.4% 0.4%
1.9% 1.0% 3.5% 0.2% 0.3% 0.4% 0.2% 0.1%
87.4% 86.6% 79.5% 96.8% 82.9% 80.0% 83.9% 88.2%
-154.4% -205.4% -229.1% -9.4% -112.6% -170.6% -328.6% -349.5%
16.6% 19.4% 17.5% 0.3% 0.6% 0.7% 1.1% 1.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?